Gleevec loses Indian patent battle

Amazon's One-Click Patent Loses Its Teeth (Micro Law)

The US Federal Circuit court of appeals has dissolved the preliminary injunction that for several years kept bar-nesandnoble.com from offering its Inter-net customers the one-click shopping that Amazon.com offers. The one-click patent, one of the most derided business-method patents, took a heavy thrashing from the Federal Circuit, but it hasn't been knocked out by complete invalidation yet. Th...

Indian Patent Law On Biotechnological Inventions

APBN • Vol. 4 • No. 4 • 2000 79 Provisions of the Patents Act, 1970 Unlike the patent laws of most developed and even some developing countries, the current patent law in India, viz. the Patents Act, 1970, does not explicitly exclude or include any biological matter. For instance, the European Patent Convention explicitly excludes the patenting of plant and animal varieties and essentially biol...

A victory for global public health in the Indian Supreme Court.

On 1 April of this year, the Indian Supreme Court upheld the decision of the Indian Patent Office to refuse the patent grant for Novartis imatinib mesylate (Gleevec). The patent application failed to meet the requirements for patentability under Indian law. The global public health community followed the case closely. Its outcome could affect the Indian generics industry - an important supplier...

Indian hepatitis C drug patent decision shakes public health community.

Reflections on the gene patent war: the myriad battle, Sputnik and beyond.

“You, or someone you love, may die because of a gene patent that should never have been granted in the first place. Sound far-fetched? Unfortunately, it’s only too real” (1 ). This quote from an editorial by the bestselling author Michael Crichton written shortly before his death is typical of the rhetoric surrounding human gene patents. Those who are against gene patents often cast them as mor...